Hypoxic pulmonary vasoconstriction: Difference between revisions
No edit summary |
(No difference)
|
Revision as of 18:17, 22 September 2011
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Overview
Hypoxic pulmonary vasoconstriction is a physiological phenomenon in which pulmonary arteries constrict in the presence of hypoxia (low oxygen levels) without hypercapnia (high carbon dioxide levels), redirecting blood flow to alveoli with higher oxygen tension.
The process might at first seem illogical, as low oxygen levels should theoretically lead to increased blood flow to the lungs to receive increased gaseous exchange. However, it is explained by the fact that constriction leads to increased bloodflow to better-aerated areas of the lung, which increases the total area involved in gaseous exchange.
External links
- American Thoracic Society
- American Journal of Physiology, Lung Cellular and Molecular Physiology
- Overview at ccmtutorials.com
Several factors inhibit this process including increased cardiac output, hypocarbia, hypothermia, acidosis/alkalosis, increased pulmonary vascular resistance, inhaled anesthetics, calcium channel blockers, PEEP, HFV, isoproterenol, nitrous oxide, vasodilators.